Corvus Pharmaceuticals (CRVS)

Corvus Pharmaceuticals (CRVS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CRVS last traded at $10.03, -1.96% on the day.
• Corvus Pharmaceuticals: market cap $843.73M, P/E -15.1, next earnings 2026-11-05.
• Over the past year CRVS returned 29.25%; year to date 30.26%.

Updated 2026-11-02 20:10 UTC